Certified by Founder Lodge
Outrun Therapeutics
United Kingdom - Dundee, Scotland
START UP
1 Disclosed Funding Rounds $10,000,000
0 Participating Investments
-
Founded date
2019
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Outrun Therapeutics is unlocking the therapeutic potential of protein stabilisation by E3 Ligase inhibition for the treatment of cancer and other diseases.
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 19 ,2024 | Seed | $10,000,000 |
M Ventures(Netherlands)
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
InCharge Energy | $46,000,000 | (Jun 5, 2026)
Forage | $40,000,000 | (Jun 5, 2026)
ZutaCore | $100,000,000 | (Jun 5, 2026)
Quobly | $133,545,475 | (Jun 5, 2026)
Oak Hill Bio | $32,500,000 | (Jun 5, 2026)
